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Abstract
Guanine-quadruplexes (G4) included in RNA molecules exert
several functions in controlling gene expression at post-tran-
scriptional level; however, the molecular mechanisms of G4-
mediated regulation are still poorly understood. Here, we
describe a regulatory circuitry operating in the early phases of
murine muscle differentiation in which a long non-coding RNA
(SMaRT) base pairs with a G4-containing mRNA (Mlx-c) and
represses its translation by counteracting the activity of the
DHX36 RNA helicase. The time-restricted, specific effect of lnc-
SMaRT on the translation of Mlx-c isoform modulates the
general subcellular localization of total MLX proteins, impacting
on their transcriptional output and promoting proper myogenesis
and mature myotube formation. Therefore, the circuitry made of
lnc-SMaRT, Mlx-c, and DHX36 not only plays an important role in
the control of myogenesis but also unravels a molecular mecha-
nism where G4 structures and G4 unwinding activities are regu-
lated in living cells.
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Introduction
Long non-coding RNAs (lncRNAs) belong to a complex class of
transcripts which are expressed in all cell types and can be consid-
ered as key regulators of development and differentiation, thanks
to the exquisite regulation of their spatiotemporal pattern of
expression [1,2]. Loss- and gain-of-function experiments indicated
that they may play an important role in normal development and
differentiation as well as in many pathological conditions [3,4];
nevertheless, the identification of the precise mechanism of action
is still lacking for most of them. The propensity to fold into
complex secondary structures, together with their modular archi-
tecture that combines nucleic acid- and protein-binding domains
into the same molecule, confers them the ability to perform a
plethora of diverse functions [5]. The subcellular distribution of
lncRNAs is an important determinant in understanding their func-
tional role [6]: While nuclear species have been mainly linked to
epigenetic modifications and transcriptional control, cytoplasmic
lncRNAs take on a central role in different steps of post-transcrip-
tional regulation of gene expression [7–9]. They were shown to act
as decoy molecules for microRNAs or protein partners [10–12] and
to mainly affect mRNA stability [13–15] and translation [16–19].
Although in some cases specific motifs of RNA–RNA pairing have
been indicated at the basis of the lncRNA-target recognition
[13,16,17], very little is known regarding the factors that contribute
to the specificity and stabilization of these interactions. An impor-
tant component in translational regulation is represented by G-
quadruplex regions, non-canonical secondary structures that form
within G-rich DNA or RNA sequences by Hoogsteen hydrogen
bonds [20], which have been shown to require specific helicases to
be solved [21].
Here, we show a regulatory circuitry controlled by a muscle-
specific cytoplasmic lncRNA (lnc-SMaRT, Skeletal Muscle Regulator
of Translation) which is essential for proper differentiation of
murine myogenic precursors: By direct base pairing with a G-quad-
ruplex region present in the Mlx-c mRNA, it prevents its translation
in an antagonistic manner with the RNA helicase DHX36. Notably,
repression of the MLX-c protein was found to control the nuclear
localization of the other two MLX isoforms (a and b) and in turn
regulate the expression of their target genes.
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Results
Lnc-SMaRT depletion affects myoblast differentiation
Lnc-SMaRT (Skeletal Muscle Regulator of Translation) is an inter-
genic long non-coding RNA, previously named lnc-049 (MGI
Symbol: GM14635), identified as a murine skeletal muscle species
[22]. Lnc-SMaRT is composed of four exons (1409 nt, Fig 1A)
and has a predominant cytoplasmic localization (Fig 1B). Its
expression starts at day 1 of murine C2C12 muscle cell
differentiation, peaks at day 2, and decreases afterward (Fig 1C),
mirroring the profile of the early myogenic markers MyoD and
myogenin (Fig EV1A). The in vivo expression of lncSMaRT was
analyzed in different tissues obtained from control mice and
dystrophic mdx mutants, which are characterized by high levels
of muscle regeneration [23]. The mdx condition was selected due
to the observed in vitro involvement of lncSMaRT in early steps
of myogenesis. PCR analyses showed that the expression of
lncSMaRT occurs in mdx muscles while it is absent in skeletal
and cardiac muscles of wild-type mice, again suggesting that
A B C
D E
Figure 1. Lnc-SMaRT functional characterization.
A Schematic representation of the lnc-SMaRT genomic locus. Genomic coordinates and exon/intron lengths are indicated. qPCR primer location is indicated by blue
arrows, while the regions corresponding to the siRNAs target sites are indicated by red lines.
B RT–PCR on cytoplasmic (C) and nuclear (N) extracts showing the subcellular localization of lnc-SMaRT. RNA was isolated from C2C12 cells after 2 days of
differentiation. GAPDH mRNA and pre-mRNA (pre-GAPDH) were used, respectively, as cytoplasmic and nuclear controls. Representative results from three
independent experiments are shown.
C qPCR analysis of lnc-SMaRT RNA expression in C2C12 cells undergoing differentiation at the indicated time points. The RNA expression levels in qPCR analyses were
normalized against GAPDH mRNA and expressed as relative quantities with respect to GM samples set to a value of 1. Data are presented as the mean  s.e.m. of
three biological replicates (dots).
D qPCR on RNA extracts from C2C12 myoblasts treated with either control siRNAs (si-SCR) or with two different siRNAs against lnc-SMaRT (si-SMaRT-1, si-SMaRT-2)
and induced to differentiate for 2 days. The RNA expression levels in qPCR analyses were normalized against GAPDH mRNA and expressed as relative quantities with
respect to GM samples set to a value of 1. Data are presented as the mean  s.e.m. of three biological replicates (dots). Statistical analysis was performed with
ordinary analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test. ***P < 0.001.
E Representative immunofluorescence for myosin heavy chain (MHC in red) in combination with DAPI staining (in blue) C2C12 murine myoblasts transfected with
either control (si-SCR) or lnc-SMaRT siRNAs (si-SMaRT-1, si-SMaRT-2) fixed after at 2 days of differentiation. Histograms represent MHC-positive mononucleated
cells/total MHC-positive cells ratio and fusion index quantification (F.I.). At least 5 randomly chosen microscope fields of two independent biological samples were
analyzed (n > 600 cells for each field). Data are presented as the mean of the two biological replicates (dots).
Source data are available online for this figure.
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lncSMaRT plays a role also in in vivo muscle regeneration
(Fig EV1B). Interestingly, 80% downregulation of lnc-SMaRT with
two independent siRNAs (#1 and #2) in murine C2C12 cells
(Figs 1D and EV1C) produced alteration of the myogenic process
with a 50% increase of myosin heavy-chain mononucleated-posi-
tive cells (MHC+) together with a 50% reduction of the fusion
index (F.I., Fig 1E). Quantitative PCR (qPCR) analysis indicated
that while the levels of the early myogenic factors MyoD and
Myog were not affected, those of late differentiation markers such
as myocyte enhancer factor 2C (Mef2C), myosin creatine kinase
(Mck), and dystrophin (Dys) were downregulated (Fig EV1D and
E). These data allowed the placement of lnc-SMaRT activity at an
intermediate stage between early and late differentiation; indeed,
lnc-SMaRT could be placed downstream of MyoD and Myog since
these proteins were shown to bind the lnc-SMaRT putative
promoter region (Chip seq data sets from Mouse ENCODE Project
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE36024)
inspected in [22]) and also because they were not affected in
conditions of lnc-SMaRT depletion (Fig EV1D and E).
Total RNA-Seq analysis was performed on two independent
populations of C2C12 cells treated with siRNA#1 and control scram-
ble siRNA. This analysis showed that lnc-SMaRT (RPKM 17.46) is a
medium-high abundant lncRNA being expressed only 3.6 times less
than MyoD (RPKM 62.42) and 4 times less that lincMD1 (RPKM of
69.9), that is considered a fairly abundant muscle-specific lncRNA
[24]. As shown in Fig EV2A, even if gene expression profiles of lnc-
SMaRT-depleted samples were more dissimilar with respect to
control samples, several genes were found to be consistently altered
upon lnc-SMaRT depletion, with the majority of them (112 out of
184) being downregulated (Fig 2A and B, Dataset EV1). Gene Ontol-
ogy (GO) term enrichment analysis showed that many downregu-
lated genes are involved in muscle contraction and steroid
biosynthesis, while the upregulated genes were mostly related to
cell proliferation (Fig 2C, Dataset EV2). Selected deregulated
mRNAs were validated by qPCR in samples independently treated
with the two lnc-SMaRT siRNAs (#1 and #2). In particular, coher-
ently with the RNA sequencing data and the observed phenotype,
Lrrn1, Tnnc2, and Crabp2 mRNAs, physiologically upregulated
during C2C12 differentiation [25,26], resulted downregulated
(Fig EV2B).
In conclusion, these data showed that lnc-SMaRT plays an
important role in controlling the correct timing of myoblast differen-
tiation with a clear effect on genes involved in intermediate stages
of myogenesis.
In the attempt to perform a rescue experiment and since plasmid
transfection of C2C12 cells is very inefficient, we raised a stable
C2C12 cell line overexpressing mature lnc-SMaRT amplified from
cDNA under the control of eIF1a promoter. Unfortunately, the over-
expressing line displayed an apoptotic phenotype which hindered
such type of analysis: In fact, myoblasts overexpressing the lncRNA
were impeded to enter the myogenic program upon serum starva-
tion by displaying only few elongated and oriented cells and
decrease in mRNA and protein levels of MyoD and myogenin
(Fig EV2D). Notably, at 48 h of differentiation, we observed an
apoptotic phenotype, as indicated by increased activation of caspase
3 (Fig 2D) and TUNEL assay (Fig EV2E). The increase in apoptosis
and consequent reduction of the number of cells maintained in the
myogenic program can explain the decrease in MyoD and myogenin
as well as the increase of transcripts related to cell proliferation
observed upon lnc-SMaRT depletion. Altogether, these data indicate
that the amount and timing of lnc-SMaRT expression should be
finely regulated to establish a correct myogenic program.
Identification of lnc-SMaRT interactors
To identify the binding partners of lnc-SMaRT, RNA pull-down
experiments were performed with two sets of biotin-labeled DNA
antisense oligonucleotides (Set#1 and Set#2, Fig 3A) on extracts
derived from C2C12 cells at day 2 of differentiation. A set of anti-
sense oligonucleotides against LacZ mRNA (LacZ), with a similar
GC content, was used as a negative control. Proteins and RNA puri-
fied after streptavidin capture of the molecular complexes were
subjected to mass spectrometry (MS) and NGS analysis, respec-
tively. The MS data allowed to short list three bona fide interactors
(PURB, IQGA1, and DHX36) based on the number of unique
peptides (more than 5) and on the enrichment with both sets of
specific oligos in comparison with LacZ probes. PUR b is a single-
stranded DNA- and RNA-binding protein that has been previously
involved in DNA replication/transcription and in mRNA translation
[27], while IQGA1 is a Ras GTPase-activating-like protein that
belongs to a family of scaffolding proteins involved in several cellu-
lar processes such as cell cycle regulation, cell–cell adhesion, and
actin cytoskeleton organization [28]. The ATP-dependent RNA heli-
case DHX36 was selected because of the absence of peptides in the
LacZ sample (Dataset EV3). This enzyme had been previously
shown to bind and unwind G-quadruplex (G4) structures in both
DNA and RNA molecules [29–31]. Western blot analysis with
DHX36 antibodies validated the strong and specific enrichment of
this protein in the lnc-SMaRT pull-downs obtained with both sets of
specific probes (Fig 3B). Finally, RNA immunoprecipitation (RIP)
performed with DHX36 antibodies and appropriate controls further
confirmed the association of the helicase with lnc-SMaRT (Fig 3C).
We also performed RNA-seq analysis of the RNAs recovered
from lnc-SMaRT pull-down; apart from lnc-SMaRT, which served as
a positive control, we identified a set of significantly enriched tran-
scripts deriving from 17 protein-coding genes (Table EV1). We did
not find any GO terms enriched in this list; however, 12 out of 17
genes resulted to encode for mRNAs with a predicted G-quadruplex
(QGRS Mapper software [32], Table 1). Since DHX36, a protein
known to solve RNA G4 structures, was found among the major
interactors of lnc-SMaRT, we concentrated on this class of tran-
scripts. Among them, we selected the Mlx mRNA due to its known
role in controlling myogenesis through the induction of several
myokines [33]. Moreover, such a transcript is present in three
isoforms (a, b, and c) that have altogether an expression level
(RPKM 23.88) similar to that of lnc-SMaRT (RPKM 17.46). Notably,
all the three isoforms (a, b, and c) resulted enriched in the pull-
down of lnc-SMaRT (Fig 3D). Pull-down experiments performed in
psoralen-crosslinking conditions allowed to further confirm the
direct pairing between Mlx mRNAs and lnc-SMaRT (Fig EV3A, left
panel). Notably, when the psoralen-crosslinking pull-down was
performed upon the depletion of lnc-SMaRT, the enrichment of Mlx
mRNA was lost (Fig EV3A, right panel).
Sequence analysis indicated that the Mlx mRNAs display a
double interaction with lnc-SMaRT: all three isoforms contain an
extended region of complementarity in their 30UTR, while only the
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Mlx-c isoform has a second pairing region located in its specific first
exon (Fig EV3B and C, see pairing of Mlx isoforms with A and B
regions of lnc-SMaRT). When analyzed with the QGRS Mapper soft-
ware [32], this region resulted to contain a bona fide G4 element.
Notably, immunoprecipitation with DHX36 antibody showed that
only the Mlx-c isoform was enriched in the IP fraction (Fig 3E,
upper panel) and that this enrichment was maintained also in the
absence of lnc-SMaRT (Fig 3E, lower panel). These results indicated
that Mlx-c is the only isoform able to interact with the helicase,
likely through the G4 element, and that this interaction can occur
even in the absence of lnc-SMaRT. When RNAi against lnc-SMaRT
or DHX36 was applied to C2C12 cells induced to differentiate, no
differences in the levels of the three Mlx mRNA isoforms were found
(Fig EV3D), prompting us to test whether any regulation could
occur at the translational level. Since the three MLX isoforms are dif-
ficult to be distinguished on Western blots, we raised plasmid
constructs expressing flagged versions of MLX-a, MLX-b, and MLX-c
and tested their behavior in conditions of lnc-SMaRT
A
C
DB
Figure 2. lnc-SMaRT depletion impacts on C2C12 transcriptome.
A Gene expression heatmap showing the hierarchical clustering of protein-coding genes whose expression is altered upon lnc-SMaRT depletion. Expression values,
calculated as RPKMs, were log2-transformed and mean-centered. Only genes with an average RPKM between 10 and 1,000 were plotted.
B Volcano plot describing the differential gene expression between si-SCR- and si-SMaRT-treated C2C12 samples. For each gene, log2 of fold-change versus log10 of
the unadjusted P-value is plotted. Points in red represent differentially expressed genes (FDR-adjusted P-value < 0.05).
C Word cloud representing the Gene Ontology Biological Process terms enriched (Benjamini–Hochberg-corrected P-value < 0.05) in the lists of genes upregulated (UP)
or downregulated (DOWN) upon lnc-SMaRT knockdown. The size of the words correlates with the Benjamini–Hochberg-corrected P-value.
D Western blot on protein extract from control and lnc-SMaRT overexpressing C2C12 stable cell lines collected after 1 day of differentiation. CASP3 antibody was used.
ACTN was used as loading control. Representative results from three independent experiments are shown.
Source data are available online for this figure.
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overexpression. HeLa cells were selected since they can be effi-
ciently transfected and because, while expressing DHX36, they are
devoid of lnc-SMaRT. The overexpression of lnc-SMaRT produced
a consistent decrease of Mlx-c translation and not of the a- and b-
isoforms (Fig 3F, upper and middle panels), without affecting the
RNA levels (Fig 3F, lower panel), indicating that lnc-SMaRT acts
as a repressor of Mlx-c translation. Downregulation of DHX36
(Fig EV3E) also reduced the MLX-c protein (Fig 3G, upper panel),
while no effects were observed at the RNA level (Fig 3G, lower
panel), indicating that the helicase is indeed required for promot-
ing Mlx-c translation. In conclusion, these data indicate that
DHX36 and lnc-SMaRT act in an antagonistic manner on Mlx-c
translation.
Lnc-SMaRT controls the subcellular localization of Mlx proteins
Due to the absence of specific antibodies for MLX-c and since this
isoform was previously shown to re-localize MLX-a and MLX-b into
the nucleus upon homodimerization [34], we decided to check by
in situ immunofluorescence whether alterations in MLX-c levels could
in turn affect the localization of total MLX proteins. We performed
such assay in C2C12 cells at day 2 of differentiation in conditions of
Mlx-c mRNA depletion (Fig EV4A). The results indicate that, with
respect to scramble siRNAs (panel si-SCR), the downregulation of
Mlx-c (panel si-Mlx-c) produced a clear decrease in the nuclear MLX
mean fluorescence (Fig 4A). The same effect was obtained when
DHX36 depletion was performed (panel si-DHX36), indicating that the
helicase controls the MLX-c protein levels. When the same analysis
was performed upon lnc-SMaRT depletion (panel si-SMaRT), a signifi-
cant increase of the nuclear MLX mean fluorescence was observed.
The quantifications of the nuclear versus cytoplasmic MLX mean fluo-
rescence ratios are indicated in Fig 4B. Notably, no alteration of the
Mlx-c mRNA levels was observed in conditions of lnc-SMaRT and
DHX36 depletion (Fig EV4A). Finally, the double knock down of Mlx-
c and lnc-SMaRT showed that the nuclear/cytoplasmic ratio of the
MLX proteins was rescued to control levels (Fig EV4B). Altogether,
these data show that MLX-c is required for the nuclear accumulation
of total MLX proteins and that the same effect is obtained upon
A
B
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Figure 3.
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downregulation of lnc-SMaRT. Therefore, these results pointed to an
inverse correlation between lnc-SMaRT levels and those of the MLX-c
protein. Further evidence for this anti-correlation is derived from
immunofluorescence experiments where the nuclear localization of
MLX was studied along C2C12 differentiation. The results indicated a
clear inverse correlation between the amount of nuclear MLX protein
and lnc-SMaRT expression; in fact, the lowest levels of nuclear MLX
were observed at the time point when lnc-SMaRT expression was
maximum (Fig EV4C and D). This occurred despite the unaltered
levels of Mlx-cmRNA (Fig EV4E).
Finally, the link between nuclear localization of MLX and its
transcriptional activity was tested by intersecting its target genes in
C2C12 cells (identified in [33]) with those deregulated upon lnc-
SMaRT depletion. We found that the expression of a significant
number of genes changed in the opposite direction upon the deple-
tion of MLX and lnc-SMaRT (Fig 4C). qPCR analysis of CCL2 and
CCL7, which are upregulated by MLX, showed their upregulation
upon lnc-SMaRT depletion at day 2 of differentiation (Fig EV4F and
Dataset EV1). In conclusion, these results suggest that lnc-SMaRT
could act as a repressor of Mlx-c translation and that in turn this
directly affects the nuclear localization of total MLX proteins and
their transcriptional output.
Lnc-SMaRT controls the translation of Mlx-c through direct base
pairing with the G4-containing region
To assess the involvement of lnc-SMaRT in Mlx regulation and the
role of the two distinct interacting regions, luciferase assays were
performed using three different reporter constructs (Fig 5A, left
panel). RLuc-Mlx 50 harbors the G4-containing region present in
the first exon of Mlx-c, cloned in-frame to the Renilla luciferase
ORF (RLuc), mimicking its position in the corresponding mRNA.
RLuc-Mlx 30 contains the 30UTR of Mlx (that includes the second
region of interaction with lnc-SMaRT), cloned downstream of the
RLuc ORF, while RLuc-Mlx 50-30 carries both elements. Each
reporter construct was co-transfected in proliferating C2C12 cells
(where lnc-SMaRT is not expressed) with either an empty vector
or with a plasmid expressing lnc-SMaRT (Fig EV5A, right panel).
Figure 5A (right panel) shows that, with respect to the activity
measured in the absence of lnc-SMaRT (#1), a 27% decrease of
luciferase levels was reproducibly obtained when RLuc-Mlx 50-30
was co-transfected with lnc-SMaRT (#2). Such effect was repro-
duced with RLuc-Mlx 50 (#3) and not with RLuc-Mlx 30 (#4).
Notably, in all cases the luciferase mRNA levels were not altered
(Fig EV5A, left panel). These data indicated that lnc-SMaRT is able
to mediate specific translational repression on the luciferase
constructs and that the region containing the G4 element is the
mediator of such regulation.
To verify the contribution of DHX36 in the regulation of RLuc-
Mlx 50, the luciferase assay was performed in cells treated with
siRNAs against DHX36, with or without the overexpression of
lnc-SMaRT (Fig EV5B). As shown in Fig 5B, the luciferase expres-
sion was reduced when samples were depleted of DHX36,
independently from the presence of lnc-SMaRT. These data indi-
cate that DHX36 plays a positive role in the translational control
of the G4 element. Interestingly, in conditions of DHX36
depletion, the presence of lnc-SMaRT was able to further decrease
luciferase activity, indicating that base pairing per se plays a
negative role on translation.
To further investigate the nature of the interactions leading to
translational repression, several other luciferase constructs were
made. A derivative of RLuc-Mlx 50 was produced by deleting 75
nucleotides encompassing the whole interacting region (RLuc-
MlxD75, Fig 5C), including the G4-element. When this latter construct
◀ Figure 3. Lnc-SMaRT molecular interactome.A Localization on the lnc-SMaRT transcript of the two sets of biotinylated probes (Set#1 and Set#2) used for lnc-SMaRT pull-down experiment.
B Left panel: qPCR analysis of lnc-SMaRT enrichment in the RNA pull-down performed in C2C12 cells at day 2 of differentiation (D2); Set#1 and Set#2 probes were used
against lnc-SMaRT together with a control set of probes against LacZ mRNA (LacZ). Data are expressed in percentage of input and presented as the mean  s.e.m. of
three biological replicates (dots). Right panel: Western blot analysis showing the specific enrichment of the DHX36 helicase in lnc-SMaRT pull-down; GAPDH was used
as negative control. Representative results from three independent experiments are shown.
C Upper panel: Western blot with DHX36 antibodies on protein extracts from DHX36 RNA immunoprecipitation. Input sample (IN) accounts for 2.5% of the extract.
Representative results from three independent experiments are shown. Lower panel: qPCR analysis of lnc-SMaRT enrichment in DHX36 RIP-derived RNA extracts.
WBP4 was used as positive control [31], while Neat1 (a lncRNA expressed at comparable level of lnc-SMaRT according to the RNA sequencing) and Rps7 were used as
negative controls. Data are expressed as percentage of input normalized on IgG control and presented as the mean  s.e.m. of three biological replicates (dots).
D RT–PCR validation of Mlx-a, Mlx-b, and Mlx-c mRNA enrichment upon the lnc-SMaRT pull-down performed with Set#1 and Set#2 probes; a control set of probes
against LacZ mRNA (LacZ) was used as negative control. GAPDH was used as negative control. Input sample (IN) accounts for 10% of the extract. Representative
results from three independent experiments are shown.
E RT–PCR analysis of Mlx-a, Mlx-b, and Mlx-c mRNA enrichment in DHX36 RIP-derived RNA extracts in samples treated with control siRNA (si-SCR, upper panel) or
siRNA against lnc-SMaRT (si-SMaRT, lower panel). GAPDH was used as negative control. Input sample (IN) accounts for 10% of the extract. Representative results
from three independent experiments are shown.
F Upper panel: Western blot with FLAG antibody on protein extracts from HeLa cells overexpressing the indicated isoforms of FLAG-tagged MLX (MLX-a, MLX-b, and
MLX-c) in control condition (CTRL) or in overexpression of lncSMaRT (OE). FLAG tag has been inserted at the N-terminus of MLX protein isoforms. HPRT was used as
loading control. Representative results from three independent experiments are shown. Middle panel: Quantification of FLAG-tagged protein levels normalized on
HPRT signals. Data are expressed as the mean  s.d. of three biological replicates (dots). Statistical analysis was performed with two-way ANOVA followed by
Bonferroni’s multiple comparisons test. ***P < 0.001. Lower panel: RT–PCR analysis of lnc-SMaRT and Mlx expression on RNA extracts from HeLa cells overexpressing
the indicated isoforms of flagged MLX (MLX-a, MLX-b, and MLX-c) in control condition (CTRL) or in overexpression of lncSMaRT (OE). GAPDH was used as loading
control. Representative results from three independent experiments are shown.
G Upper panel: Western blot with FLAG antibodies on protein extracts from N2a cells transfected with an empty vector (CTRL) or with a plasmid overexpressing FLAG-
tagged MLX-c (MLX-c) in control conditions (si-SCR) or upon knockdown of DHX36 (si-DHX36). ACTININ was used as loading control. Representative results from three
independent experiments are shown. Lower panel: RT–PCR analysis of Mlx-c expression on the described RNA extracts. GAPDH was used as loading control.
Representative results from three independent experiments are shown.
Source data are available online for this figure.
6 of 17 EMBO reports e49942 | 2020 ª 2020 The Authors
EMBO reports Julie Martone et al
was compared to the behavior of RLuc-Mlx 50 in the absence (#1) or
in the presence of lnc-SMaRT (#2), we observed the loss of respon-
siveness to lnc-SMaRT repression (#3) with the recovery of luciferase
activity up to control levels. An additional construct was obtained by
replacing 30 nucleotides of the Mlx-c sequence containing the G4-
element, with the corresponding pairing region of lnc-SMaRT (Ruc-
Mlxmut30). This construct failed to respond to lnc-SMaRT repression
(#4); however, when the base pairing was restored by inserting into
Table 1. G-quadruplexes predicted on transcripts from protein-coding genes recovered from lnc-SMaRT pull-down.
Gene ID Start End G4 G-score Localization
Acad8 ENSMUST00000060513 299 334 GGGATTTGGGGGGGTCTATGTGCGAACAGATGTGGG 52 CDS
Acad8 ENSMUST00000120367 1 15 GGGGGGCGGGGCGGG 62 50UTR
Acad8 ENSMUST00000120367 316 351 GGGATTTGGGGGGGTCTATGTGCGAACAGATGTGGG 52 CDS
Acsl6 ENSMUST00000108905 24 48 GGGGCTGCGGGGCTGCGGGCCTGGG 62 50UTR
Acsl6 ENSMUST00000127731 2,807 2,838 GGGTTGGGATTCTGGGTGTTCTCCATGGAGGG 56 /
Acsl6 ENSMUST00000127731 2,615 2,654 GGGTGGGATGGGGTAGTTCATGTCTAGGGTTGAGAGTGGG 60 /
Acsl6 ENSMUST00000108904 24 48 GGGGCTGCGGGGCTGCGGGCCTGGG 62 50UTR
Arf5 ENSMUST00000020717 1,013 1,056 GGGGGTACCCTTGGGGCCAGGTTTTGGGGGGAGGAAAGTGAGGG 63 30UTR
Coq2 ENSMUST00000126981 20 51 GGGAGGCGCGGGGCTCGCGCGGGGCCTGCGGG 63 /
Coq2 ENSMUST00000126981 114 155 GGGGTTCCGGGCGCGCGGGATCGGCGAGCCCCGGCCCCCGGG 54 /
Coq2 ENSMUST00000135146 21 62 GGGGTTCCGGGCGCGCGGGATCGGCGAGCCCCGGCCCCCGGG 54 /
Coq2 ENSMUST00000031262 55 86 GGGAGGCGCGGGGCTCGCGCGGGGCCTGCGGG 63 CDS
Coq2 ENSMUST00000031262 149 190 GGGGTTCCGGGCGCGCGGGATCGGCGAGCCCCGGCCCCCGGG 54 CDS
Glis3 ENSMUST00000065113 2,048 2,086 GGGCACTCCCCAGGGCCGGGGCCTGGGCCAGGGCCTGGG 64 /
Glis3 ENSMUST00000162022 2,667 2,705 GGGCACTCCCCAGGGCCGGGGCCTGGGCCAGGGCCTGGG 64 CDS
Glis3 ENSMUST00000162022 7,280 7,322 GGGGATGGTGATTATAATTAAAAGCAGATGGGGGGGGAAGGGG 67 30UTR
Glis3 ENSMUST00000161026 1,713 1,751 GGGCACTCCCCAGGGCCGGGGCCTGGGCCAGGGCCTGGG 64 /
Mlx ENSMUST00000017945 98 114 GGGGAGGGCGGGTCGGG 63 CDS
Myo1c ENSMUST00000102505 4,451 4,485 GGGTGCCTCTGTGACCTGGGAGCCTAGGGACAGGG 56 30UTR
Myo1c ENSMUST00000108431 4,519 4,553 GGGTGCCTCTGTGACCTGGGAGCCTAGGGACAGGG 56 30UTR
Myo1c ENSMUST00000108431 4,402 4,422 GGGAGCTACCGGGTGGGAGGG 60 30UTR
Myo1c ENSMUST00000108431 280 324 GGGCAGCGGAGCGGGGCGCCGGGTCCGGCAGGATGCGCTACCGGG 54 50UTR-CDS
Myo1c ENSMUST00000108431 200 230 GGGGCCTGCAAGGGGCGGTGCAGGGGGCGGG 60 50UTR
Myo1c ENSMUST00000102504 4,458 4,492 GGGTGCCTCTGTGACCTGGGAGCCTAGGGACAGGG 56 30UTR
Myo1c ENSMUST00000069057 4,229 4,249 GGGAGCTACCGGGTGGGAGGG 60 30UTR
Myo1c ENSMUST00000069057 4,346 4,380 GGGTGCCTCTGTGACCTGGGAGCCTAGGGACAGGG 56 30UTR
Myo1c ENSMUST00000102505 4,334 4,354 GGGAGCTACCGGGTGGGAGGG 60 30UTR
Myo1c ENSMUST00000102504 4,341 4,361 GGGAGCTACCGGGTGGGAGGG 60 30UTR
Ndrg4 ENSMUST00000041318 2,377 2,413 GGGCTGGAGATTGCCTGGCCCTTGGGTGGGAAATGGG 51 30UTR
Ndrg4 ENSMUST00000080666 2,014 2,050 GGGCTGGAGATTGCCTGGCCCTTGGGTGGGAAATGGG 51 30UTR
Ndrg4 ENSMUST00000166358 2,243 2,279 GGGCTGGAGATTGCCTGGCCCTTGGGTGGGAAATGGG 51 /
Ndrg4 ENSMUST00000073139 2,079 2,115 GGGCTGGAGATTGCCTGGCCCTTGGGTGGGAAATGGG 51 30UTR
Rbm45 ENSMUST00000046389 41 75 GGGGCGAGACGGGGAGCTGCCGGGAAGCGGCCGGG 63 50UTR
Six1 ENSMUST00000050029 329 366 GGGGCGGCAGGGTGGCGCGGCTTTGCTGCCGGGCCGGG 53 50UTR
Six1 ENSMUST00000050029 1,599 1,635 GGGTTCCTAAGTGGGGAGATATTGGGGCCTTGAAGGG 63 CDS-30UTR
Spire1 ENSMUST00000115050 253 297 GGGCCCGGTTCTGGGTACAAGTGATGAGGGATTTGCGAAATGGGG 62 CDS
Spire1 ENSMUST00000082243 407 451 GGGCCCGGTTCTGGGTACAAGTGATGAGGGATTTGCGAAATGGGG 62 CDS
Spire1 ENSMUST00000045105 351 395 GGGCCCGGTTCTGGGTACAAGTGATGAGGGATTTGCGAAATGGGG 62 CDS
Usp10 ENSMUST00000144458 2,260 2,295 GGGCAAGGGCAGCGAGGACGAGTGGGAGCAAGTGGG 56 CDS
Usp10 ENSMUST00000108988 1,803 1,838 GGGCAAGGGCAGCGAGGACGAGTGGGAGCAAGTGGG 56 CDS
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lnc-SMaRT the complementary Mlx-c sequence, the luciferase activity
was strongly affected (#5). The luciferase mRNA levels, in all the
analyzed conditions, were unchanged (Fig EV5C).
These data indicated that the complementarity between the A
region of lnc-SMaRT and the G4-containing region of Mlx-c is
required to repress translation in a very specific manner.
Region A of lnc-SMaRT is able to pair with G4 elements in vitro
Synthetic RNA oligonucleotides containing the G4 region of
Mlx-c (c-oligo) and the complementary lnc-SMaRT sequence
(SMaRT-oligo) were used to test their in vitro ability to form G4
structures and to base pair (see schematic representation of
Fig 6A). Their behavior was analyzed on polyacrylamide gels in
both denaturing and native conditions. In denaturing conditions,
using SYBR Gold staining, which allows the visualization of total
RNA, a single band was observed for each oligo (Fig 6A, lanes
#1 and #2). Instead, in native conditions, two different bands
were detected with the c-oligo: One migrated as the linear form
(c-oligo), while the other showed slower mobility, possibly due
to a putative G-quadruplex structure (lane #4, c-G4 band). This
was confirmed by the use of a quadruplex-specific fluorescent
A
B C
Figure 4. Representative images for MLX immunofluorescence on C2C12 myotubes.
A Immunofluorescence for total MLX protein detection (red signal) performed on C2C12 cells treated with siRNAs against Mlx-c (si-Mlx-c), lnc-SMaRT (si-SMaRT),
DHX36 (si-DHX36), or with a control siRNA (si-SCR). Cells were fixed 2 days after the switch to differentiation medium. Representative binary images of single confocal
planes for MLX immunofluorescence are shown for each treatment. The inserts on the topside of the images sketch the MLX signal peaks in the nuclei (white stars) to
highlight the variation of MLX staining in each condition. Dashed lines indicate the edge of the nucleus.
B Histogram represents the fluorescence intensity ratio of the MLX protein signals in the nuclear (Nuc) and cytoplasmic (Cyt) compartment in the indicated conditions.
About 50 cells from two independent experiments were analyzed as indicated in Materials and Methods. Data are presented as the mean of two biological replicates
(dots).
C Venn diagram showing the overlap between genes deregulated upon lnc-SMaRT depletion and MLX targets [33], both in C2C12 samples. Genes at the intersection are
those with opposite fold-changes in the two depletion experiments. Only genes expressed in both systems were used to evaluate the overlap. Significance of overlap
was evaluated using hypergeometric test.
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dye (NMM, N-methyl mesoporphyrin IX [35,36]), which revealed
specific staining only of the c-G4 band (lane #6). Addition of
KCl, known to stabilize G4 structures [37], increased the c-G4
band upon NMM staining (Fig 6B, #2 vs #3), further supporting
the presence of a G4 structure. Differently from the c-oligo,
NMM staining did not reveal any putative G4 structure on the
SMaRT-oligo (Fig 6A, lane #5).
When the c- and SMaRT- oligos were mixed, denatured at 100°C,
and analyzed on native gel after slow renaturation, several addi-
tional bands appeared (Fig 6A, lane #8). All of them showed lower
A
B C
Figure 5. Lnc-SMaRT controls the translation of Mlx-c through direct base pairing with the G4-containing region.
A Left panel: schematic representation of the luciferase constructs produced for Mlx. Mlx 50- and 30UTR-interacting regions were cloned, respectively, upstream and
downstream the Renilla luciferase coding region (RLuc-Mlx 50-30) and mutant derivatives devoid of the 50 interacting region (RLuc-Mlx30) or the 30 UTR-interacting
region (RLuc-Mlx50) were obtained. These constructs were co-transfected in C2C12 myoblasts in growth conditions together with plasmids expressing lnc-SMaRT (+)
or with a control vector (). Right panel: Luciferase activity data, presented as the mean  s.e.m. of three biological replicates (dots), are shown with respect to each
RLuc control vector (RLuc-Mlx 50–30 , RLuc-Mlx30 , RLuc-Mlx50) set to a value of 1. Statistical analysis was performed with ordinary analysis of variance (ANOVA)
followed by Dunnett’s multiple comparison test. *P < 0.05.
B The RLuc-Mlx50 construct was co-transfected in N2a cells together with plasmids expressing lnc-SMaRT (+) or with a control vector () and treated with control
siRNA (+) or siRNA against DHX36 (). Luciferase activity data, presented as the mean  s.e.m. of three biological replicates (dots), are shown with respect to RLuc-
Mlx50 vector set to a value of 1. Statistical analysis was performed with ordinary analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test.
**P < 0.01, ***P < 0.001.
C Left panel: schematic representation of the luciferase constructs used. The RLuc-Mlx50 construct and its derived mutants (RLuc-Mlxmut30, RLuc-Mlx D75) were
transfected in N2a cells in growth conditions together with lnc-SMaRT-expressing plasmids (lnc-SMaRT) or with its derived mutant (lnc-SMaRTmut) in the indicated
combinations. Right panel: Luciferase activity data, presented as the mean  s.e.m. of three biological replicates (dots), are shown with respect to each RLuc control
vector (RLuc-Mlx50 , RLuc-Mlxmut30, RLuc-Mlx D75) set to a value of 1. Statistical analysis was performed with ordinary analysis of variance (ANOVA) followed by
Dunnett’s multiple comparison test. ***P < 0.001.
Source data are available online for this figure.
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mobility compared to the single oligos, suggesting the formation of
double-stranded structures. Interestingly, staining with NMM
showed a strong decrease of the c-G4 band (Fig 6A, compare lanes
#6 and #10), indicating that the presence of the SMaRT-oligo helped
solving the G4 structure of the c-oligo. In these conditions, a second
band resulted positive to NMM (band*). The pairing between c- and
SMaRT- oligos further increased by previous denaturation (Fig 6B,
#4 and #5) to the detriment of c-G4 formation (NMM staining in
Fig 6C, #4 and #5). On the contrary, pairing was strongly reduced
after stabilization of the G4-structure by KCl (Fig 6B and 6C, #6) as
indicated by the increase of both the linear SMaRT-oligo (Fig 6B,
#6) and of the c-G4 (Fig 6C, #6) bands.
In conclusion, these experiments show that the G4 sequence in
Mlx-c can indeed form a G4 structure and that in the presence of the
complementary region present in lnc-SMaRT the same region can be
engaged to form a duplex.
A
B C
Figure 6.
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Discussion
Guanine-quadruplexes (G4) consist of non-canonical four-stranded
helical arrangements of guanine-rich nucleic acid sequences. In RNA,
G4 regions may act in both the nucleus and the cytoplasm, exerting
different post-transcriptional effects ranging from RNA processing to
localization, stability, and translation [38]. Indeed, G4 sequences
were found in quite a high number of transcripts with localization in
50 and 30 UTRs as well as in CDS regions [39] and several reports
correlated the presence of G4 sequences in 50UTRs with translational
repression [40–42]. Resolution of G4 structures in vivo requires
specialized enzymes, among them the DHX36 RNA helicase, belong-
ing to the DEAH-box family. This protein exhibits ATP-dependent G4
unwinding activity and it was shown to associate to more than 100
G4-containing RNAs [31]. DHX36 recognizes G4 sequences in 50 and
30 UTRs and controls both mRNA translation and stability [43]
through its helicase activity; moreover, it can also interplay with
microRNA-mediated translational regulation at G4 elements present
in 30UTRs [44]. However, how the activity of the enzyme on these
targets is regulated in vivo and what are the molecular mechanisms
of G4-mediated regulation still remain open questions.
Here, we describe the function of a lncRNA which enters the
pathway of the DHX36 helicase and of one of its specific G4-
substrates. lnc-SMaRT, by base pairing with the G4-containing
region of Mlx-c mRNA, prevents its translation in an antagonistic
manner with DHX36. Lnc-SMaRT is specifically expressed in early
phases of myogenesis and elicits an important function since its
depletion leads to alteration in the differentiation program with
defects in myoblast fusion. Notably, its overexpression produced a
clear apoptotic phenotype. In the myogenic lineage, induction of
differentiation and apoptosis share a number of cellular mechanisms
that involve several caspase family members [45], such as the case
of caspase 3 activity required to control correct myotube formation
[46]. In this landscape, our data indicate that lnc-SMaRT should be
finely controlled in time and quantity in order to fine-tune the
balance between differentiation and apoptosis and to ensure proper
myogenesis.
Among putative interactors of lnc-SMaRT, we validated the Mlx
mRNA by both native and psoralen-crosslinking pull-down condi-
tions. We show that while all three Mlx isoforms (a, b, and c) share
an extended region of complementarity with lnc-SMaRT in their
30UTR, only Mlx-c contains a second sequence of complementarity
located in the CDS. Notably, this second region includes a G4-
element which provides the ability to bind the DHX36 helicase.
While the base pairing between the G4-contaning element of Mlx-c
and lnc-SMaRT conferred translational control, the 30UTR-pairing
region did not. It is possible that since the luciferase assays were
performed in overexpression conditions of both lnc-SMaRT and luci-
ferase constructs, the effect of the 30UTR-pairing region could have
been underscored; therefore, we cannot exclude that in endogenous
conditions this pairing could cooperate for a more efficient recogni-
tion of lnc-SMaRT for the target mRNA.
MLX proteins were described as myogenic transcriptional factors
able to activate a specific class of myokines and to regulate myogen-
esis in response to glucose signaling [33]. We demonstrated that the
three MLX isoforms are part of a regulatory loop where MLX-c regu-
lates the nuclear re-localization of the other two. In fact, Mlx-c
mRNA downregulation decreased the global levels of MLX proteins
inside the nucleus and in turn affected the expression of several
target genes. We showed that lnc-SMaRT enters in this circuitry by
controlling the translation of MLX-c and in turn the overall amount
of the nuclear MLX proteins. Interestingly, along the myogenic dif-
ferentiation process, the amount of MLX inside the nucleus inver-
sely correlated with lnc-SMaRT expression, again supporting the
inhibitory effect of the lncRNA on MLX-c synthesis.
In the overall, this circuitry combines the translational control of
the MLX-c isoform by lnc-SMaRT with consequent regulation of the
subcellular localization of the total MLX proteins and their transcrip-
tional outcome. This should occur at very specific and restricted
stages during in vitro differentiation likely ensuring the fine-tuning
and robustness to the myogenic process. Indeed, lnc-SMaRT was
shown to be present in vivo only in dystrophic muscles of mdx mice,
known to undergo extensive regeneration of muscle fibers. There-
fore, it is possible that lnc-SMaRT might control the fine balance
between proliferation and differentiation required to control muscle
homeostasis during differentiation and regeneration conditions.
The search for putative G-quadruplex forming sequences in lnc-
SMaRT with the QGRS Mapper software [32] and with the “Quad-
Base2″ tool [47] did not predict the occurrence of bona fide G4-
elements. Therefore, it is likely that the interaction of lnc-SMaRT
and DHX36 is indirect. One hypothesis is that region B can mediate
the initial interaction between lnc-SMaRT and the DHX36/Mlx-c
complex; in turn, the helicase would favor the formation of the pair-
ing between region A and the G4-containing sequence producing the
◀ Figure 6. In vitro characterization of the interaction between lnc-SMaRT and Mlx-c pairing sequences.A Upper panel: schematic representation of the predicted base pairing between lnc-SMaRT (region A) and Mlx c mRNA; the predicted G4 structure is boxed in red, while
the synthetic oligos sequences are underlined in red. Lower panel: Lanes 1 and 2: 5 pmol of lnc-SMaRT and Mlx synthetic oligos were loaded on a denaturing
polyacrylamide gel and stained for total RNA (SYBR GOLD, indicated as SYBR in the figure). Lanes 3 and 4: 5 pmol of lnc-SMaRT and Mlx synthetic oligos were loaded
on a native polyacrylamide gel and stained for total RNA (SYBR GOLD). Lanes 5 and 6: 200 pmol of lnc-SMaRT and Mlx synthetic oligos were loaded on a native
polyacrylamide gel and stained with the selective G-quadruplex staining N-methyl mesoporphyrin IX (NMM). Lanes 7 and 8: 5 pmol of Mlx oligo alone (7) or in
combination with 5pmol of lnc-SMaRT-oligo (8) were heated at 100°C for 10 min and, after slow cooling, loaded on a native polyacrylamide gel, and stained for total
RNA (SYBR GOLD). Lanes 9 and 10: 200 pmol of Mlx oligo alone (7) or in combination with 200 pmol of lnc-SMaRT-oligo (8) were heated at 100°C for 10 min and,
after slow cooling, loaded on a native polyacrylamide gel and stained with the selective G-quadruplex staining N-methyl mesoporphyrin IX. Asterisk (*) indicates the
second NMM-positive band obtained upon SMaRT and c-oligo interaction.
B 5 pmol of indicated oligos were loaded on a native polyacrylamide gel. Oligos were treated as described. °C = oligos were heated (+) or were not heated () at 100°C
for 10 min and loaded after slow cooling. KCl = oligos were incubated (+) or were not () in a buffer containing 100 mM KCl (for G-quadruplex stabilization). The gel
was stained with total RNA staining (SYBR GOLD).
C 200 pmol of indicated oligos treated as in (B) were loaded on a native polyacrylamide gel with the selective G-quadruplex staining N-methyl mesoporphyrin IX.
Asterisk (*) indicates the second NMM-positive band obtained upon SMaRT and c-oligo interaction.
Data information: Representative gels from at least three independent experiments are shown.
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inhibitory double-stranded structure. This would be in agreement
with the finding that DHX36 is able to unwind quadruplex regions
and to promote the formation of double-stranded pairing with other
RNA sequences [30].
Comparative genomics analysis indicated that the MLX locus is
conserved among mammals, starting from Opossum up to human;
moreover, in the same species, the Mlx transcript is present in multi-
ple isoforms. Notably, the G4 element present in Mlx-c also resulted
highly conserved, pointing to the important role of these sequences
in controlling Mlx production. On the contrary, search for a human
counterpart of lnc-SMaRT did not show any conserved synthenic
RNA, suggesting that the presence of such sequence in mouse origi-
nated from a divergent functional evolution. The region of lnc-
SMaRT pairing with the G4 element of Mlx-c resulted as part of a
LINE element, derived from non-LTR retrotransposons [48]. The
interesting aspect of the origin, evolution, and functional diversifi-
cation of lncRNAs is the presence of repetitive sequences, in particu-
lar transposable elements (TE), which are “mobile” sequences able
to change their position in the genome. Several roles have been
attributed to TE in regulating genome evolution, gene expression,
genetic instability, and cancer disposition. Notably, the content of
TE-derived sequences in lncRNA genes is greater than in protein-
coding genes, and it reaches 51% of the mouse lincRNAs [49]. Due
to their increased abundance in evolution, it is likely that TE
elements have contributed to the evolution and functional diversifi-
cation of lncRNAs in different species, not only in animals but also in
other eukaryotic kingdoms such as plants [50]. Therefore, it is possi-
ble that TE spreading has provided an evolutionary drive to increase
the RNA–RNA “interactive” potential [51] and that another lncRNA
in human may have acquired the ability to control G4 elements.
Materials and Methods
Cell culture and treatments
C2C12 murine myoblast (ATCC) were maintained in proliferating
conditions in growth medium (Dulbecco’s modified Eagle’s medium
supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 lg/
ml streptomycin, 20% fetal bovine serum) and induced to differenti-
ate in differentiation medium (FBS reduced to 0.5%). HeLa cells
were cultured in Dulbecco’s modified Eagle’s medium supplemented
with 2 mM L-glutamine, 100 U/ml penicillin, 100 lg/ml strepto-
mycin, and 10% fetal bovine serum. N2a cells were cultured in
minimum essential medium Eagle (M2279, Sigma), supplemented
with 2 mM L-glutamine, sodium pyruvate 1 mM, 1× MEM non-
essential amino acid solution (M7145, Sigma), 10% FBS premium
USA sourced (45001-106, Corning), 100 U/ml penicillin, and
100 lg/ml streptomycin.
For siRNAs, reverse transfection was performed as follows: For a
3.5-cm culture dish, 5 ll of Lipofectamine RNAiMAX (Thermo
Scientific) was added to 300 ll of Opti-MEM I reduced serum
medium (Gibco); the siRNA was then added at a final concentration
of 30 nM for a final volume of 2 ml. After 15 min of incubation at
room temperature, the transfection mix was distributed on the
culture dish and 200,000 C2C12 cells were seeded in GM. After
24 h, cell confluency was checked and the culture medium was
replaced with DM, in order to trigger the differentiation; cells were
collected 48 h after the induction. Scramble and DHX36 siRNA were
purchased from Qiagen (AllStars Negative Control siRNA and Mm
Dhx36-4 FlexiTube, respectively), while lnc-SMaRT siRNAs were
custom-synthetized (Qiagen). Plasmid DNA transfection was
performed using Lipofectamine 2000 (Thermo Fisher Scientific)
according to the manufacturer’s specifications.
RNA extraction and analysis
RNA extraction was performed with the Direct-zol Miniprep RNA
Purification Kit (Zymo Research) with on-column DNase treatment,
according to the manufacturer’s instructions. For RNA pull-down
and RIP experiments, the RNA was extracted using QIAzol reagent
and miRNEasy spin columns (QIAGEN), according to the manufac-
turer’s specifications.
For routine experiments, total RNA was retro-transcribed with
PrimeScriptTM RT Reagent Kit (Takara) according to the manufac-
turer’s instructions while, for low RNA input experiments (RNA
pull-down and RIP), the Superscript VILO cDNA Synthesis Kit was
used (Life Technologies). Samples were then analyzed by qPCR
using PowerUp SYBR Green Master Mix (Thermo Fisher Scientific)
or by semi-quantitative RT–PCR using MyTaqTM DNA polymerase
(Bioline). The oligonucleotide sequences are listed in Table EV4.
Protein extraction and Western blot
Protein extract was obtained using standard RIPA buffer, supplied
with 1× Complete Protease Inhibitor Cocktail (Roche). Protein
concentration was assessed using Bradford Protein Assay (Bio-Rad).
Protein electrophoresis was performed using 4–15% Mini-PROTEAN
TGX Precast acrylamide gel (Bio-Rad) according to the manufac-
turer’s instructions, and proteins were transferred to Immobilon-E
PVDF 0.45-lm membrane (Merck-Millipore) at 80 V for 1 h in 1×
Towbin Transfer Buffer (25 mM TRIS, 192 mM glycine, 20%
methanol). Membranes were blocked with 5% non-fat dry milk
(Difco skim milk) for 1 h and incubated overnight at 4°C with the
following primary antibodies: anti-DHX36 (13159-1-AP, Protein-
tech); anti-MLX (12042-1-AP, Proteintech); anti-MyoD (M-318, Sc-
760, Santa Cruz Biotechnology); anti-MYOG (F5D, sc-12732, Santa
Cruz Biotechnology); anti-caspase 3 (9622, Cell Signaling Technol-
ogy); anti-ACTININ-4 (G-4, sc-390205, Santa Cruz Biotechnology);
anti-DYS (NCL-DYS1, Novocastra Laboratories), anti-MEF2C (sc-
365862, Santa Cruz Biotechnology), anti-GAPDH (6C5, sc-32233,
Santa Cruz Biotechnology), and anti-HPRT (FL-218, sc-20975, Santa
Cruz Biotechnology). The following secondary antibodies were
used: goat anti-rabbit HRP (31460, Invitrogen) and goat anti-mouse
HRP (32430, Invitrogen). FLAG-tagged proteins were detected with
ANTI-FLAG M2-Peroxidase (HRP) antibody (A8592, Sigma).
Protein detection was carried out with WesternBright ECL
(Advansta) using ChemiDocTM MP System and images were
analyzed using Image LabTM Software (Bio-Rad).
Native RNA pull-down
Native pull-down on C2C12 myoblasts was performed as described
in ref. [19]. The sequences of the biotinylated oligonucleotides
belonging to probe set-1, probe set-2, and LacZ control are listed in
Table EV4.
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Protein mass spectrometry
To identify unknown protein partners of lnc-SMaRT, protein mass
spectrometry after purification of RNA–protein complexes was used.
Eluted proteins from the lnc-SMaRT pull-down were loaded on a 4–
12% NuPAGE Bis-Tris gels (Life Technologies); then, the corre-
sponding gel parts of each sample were sent for mass spectrometry
analysis to the proteomic platform at IGBMC–Strasbourg, where
they were digested with trypsin and analyzed according to their
standard mass spectrometry pipeline using LTQ Velos Pro instru-
ment (Thermo Fisher). To analyze the results, stringent filtration
criteria were applied (1% false discovery rate and 2 peptides mini-
mum per protein).
DHX36 RNA immunoprecipitation
Two 10-cm plates of C2C12 (1.5 × 106) differentiated for 48 h were
collected in PLB Buffer (KCl 100 mM; MgCl2 5 mM; NP-40 0,5%;
DTT 1 mM; protease and Rnase inhibitor), incubated for 15 min at
4°C on a rotating wheel and then centrifuged at 15,000 g for
10 min at 4°C. The supernatant was recovered and protein concen-
tration was quantified by Bradford assay; 0.5 mg of extract was
used for each sample (IP and IgG) and was pre-cleared with 40 ll
of Protein G Agarose/Salmon Sperm Beads (Millipore) in a final
volume of 1 ml of NT2 buffer (Tris–HCl pH 7.4 50 mM; NaCl
150 mM; MgCl2 1 mM; NP-40 0.05%; Protease and RNase Inhi-
bitor) for 2 h at 4°C on a rotating wheel. 10% of the final volume
was taken as input, and the remaining pre-cleared lysate was incu-
bated with 5 ug of DHX36 (Proteintech, 13159-1-AP) or IgG (Santa
Cruz Biotechnology, sc-2027) antibodies overnight at 4°C. Subse-
quently, 80 ll of protein G agarose beads were added to each
sample and incubated for 2 h at 4°C. After antibody–protein
complex recovery, the beads were washed 4× in NT2 buffer and
finally re-suspended in 200 ll of NT2 Buffer. To check DHX36
immunoprecipitation efficiency, an aliquot of 50 ll of beads was
pelleted, re-suspended in 1× Laemmli sample buffer (Bio-Rad) and
50 mM DTT, and incubated at 70°C for 15 min; then, the eluate
was used for Western blot.
RNA was recovered from the remaining 150 ll of beads by re-
suspending them in 500 ll of TRI-Reagent (Zymo Research). RNA
extraction was carried out with RNeasy Plus Minikit (Qiagen)
according to the manufacturer’s protocol.
Psoralen-crosslinked RNA pull-down
Psoralen-crosslinked RNA pull-down protocol was adapted from
RICC-seq protocol [52]. C2C12 cells were plated in two 10-cm
plates at a density of 1 × 106 cell/plate and grown for 24 h before
switching to DM. After 48 h of differentiation, the medium was
replaced with fresh DM supplemented with 20 lg/ml of 40-amino-
methyl-4,50,8-trimethylpsoralen (AMT, Cayman Chemical) and
cells were incubated 30 min at 37°C. After incubation, the cells
were washed twice with complete PBS, covered with PBS supple-
mented with 150 lg/ml AMT, and crosslinked at 365 nm at 10-
min intervals for 1 h. Cells were lysed in 500 ll of guanidinium
hydrochloride 3M, and the lysate was subdivided into 150 ll
aliquots; 25 ll of a 20 mg/ml solution of RNAse-free proteinase K
(Ambion) and 7.5 ll of 20% sodium dodecyl sulfate (SDS) were
added to each aliquot; and the samples were incubated at 65°C
for 1 h with gentle agitation. RNA was precipitated with conven-
tional phenol/chloroform extraction; the rest of pull-down proto-
col was performed as described in [52], with minor
modifications.
Microscopy and image analysis
C2C12 cells were cultured on pre-coated glass coverslips (300 ug/ml
in PBS Collagen Rat Tail, Corning) and then were fixed in 4%
paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) in
PBS at 4°C for 20 min.
MHC immunofluorescence was performed as previously
described [53]. Samples were imaged on inverted microscope Zeiss
AxioObserver A1 equipped with Axiocam MRM R camera and Plan-
Neofluar EC 10×/0.3 M27 objective. Images were acquired with
AxioVision Rel.4.8 software. At least five randomly chosen micro-
scope fields of two independent biological samples were analyzed
(n > 600 cells for each field). For MLX and MHC double immunos-
taining, cells were permeabilized with Triton 0.2% for 10 min,
blocked with 2% BSA/PBS for 20 min, and subsequently incubated
at 4°C overnight with anti-MLX (Proteintech, 12042-1-AP) diluted
1:50 and with anti MHC (MF20 clone hybridoma supernatants)
diluted 1:2 in blocking solution. After serial washes in 0.1% Triton/
PBS, coverslips were incubated in 1% goat serum/1% donkey
serum/PBS with goat anti-rabbit Cy3 conjugated (1:300; Jackson
ImmunoResearch) and donkey anti-mouse AlexaFluor 488 (1:200,
Life Technologies) to detect MLX and MHC primary antibodies,
respectively. The incubations were performed for 1h at room
temperature. The specificity of immunolabeling was verified in
control samples prepared with the incubation buffer alone, followed
by the secondary conjugated antibody. The nuclei were stained with
DAPI (40,6-diamidino-2-phenylindole).
Confocal images (16-bit and 1,024 × 1,024 pixels) were acquired
with 60× NA 1.35 oil objective (UPLANSApo) on inverted micro-
scope (Olympus IX73) equipped with a Confocal Imager (CREST X-
LIGHT) spinning disk, a CoolSNAP Myo CCD camera (Photomet-
rics), and a Lumencor Spectra X LED illumination. The Z-stacks
were collected at step size of 0.2 lm with XY resolution of
0.075 lm.
In post-acquisition processing, a specific range of intensity
balance was manually determined by using MetaMorph or FIJI soft-
ware to the entire image. A qualitative display of MLX distribution
inside the cells was performed with FIJI software by threshold
processing (to obtain binary images) and local maxima filter (to
mark the peaks of MLX signals inside the nuclei).
The Nuc/Cyt fluorescence ratio (fluorescence signal intensity
inside nucleus/fluorescence signal intensity inside cytoplasm) of
MLX signals was obtained on single-focus Z-plane by measuring the
mean fluorescent intensity inside composite selections (ROI) that
delimitate subcellular compartments. Nuclear boundary was
assigned by DAPI staining, while the edge of the cells was highlight
by MHC staining. Nuc/Cyt ratio value = 1 indicates the 1:1 fluores-
cent ratio of MLX signals between nuclear and cytoplasmic compart-
ment, while Nuc/Cyt values > 1 or < 1 indicate the enrichment of
the MLX signals inside the nucleus or cytoplasm, respectively.
The fluorescence was quantified using FIJI software from about
50 cells on each condition (20 cells on each condition for rescue
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analysis shown in Fig EV4B). The value of the Nuc/Cyt ratio was
represented as mean of two biological replicates.
Acquisition and quantification of myotubes formation (mononu-
cleated MHC-positive cells and myotube Fusion Index) were
performed as described in ref. [54].
lnc-SMaRT overexpression constructs
The construct for the overexpression of lnc-SMaRT was obtained by
cloning lnc-SMaRT cDNA in a modified pCDNA3.1(+) plasmid
(Invitrogen), in which CMV promoter has been replaced with the
human EIF1a promoter sequence, using XhoI and NotI restriction
enzymes (Thermo Scientific). The lnc-SMaRTmut mutant was
obtained by inverse PCR with divergent primers from the lnc-SMaRT
overexpressing plasmid. Oligonucleotides are listed in Table EV4.
FLAG-MLX isoforms overexpression constructs
The 50UTR and coding sequence of the three MLX isoforms were
amplified from C2C12 D2 cDNA with the MLX Infusion Fw and Rv
oligonucleotides. The obtained PCR products were inserted in the
previously described pCDNA3.1-EIF1a backbone, linearized with
XhoI and NotI restriction enzymes (Thermo Scientific), using the In-
Fusion HD Cloning Kit (Clontech).
FLAG tag was in-frame inserted at the N-terminus by inverse
PCR using MLX FLAG Fw and Rv primers.
lnc-SMaRT overexpressing stable cell line
An expression cassette containing the EIF1a promoter, the lnc-
SMaRT cDNA sequence, and the BGH termination site has been
amplified from the already described lnc-SMaRT overexpression
plasmid. The cassette was subsequently inserted in the ePB-BSD-
PGK-Int-RFP [55] linearized with XhoI-BglII restriction enzymes
(Thermo Scientific) with the In-Fusion HD Cloning Kit (Clontech).
To generate the stable lnc-SMaRT overexpressing cell line, 200,000
C2C12 cells were transfected with 5 lg of SMaRT-ePB-BSD-PGK-Int-
RFP and 500 ng of the piggyBac transposase vector. Cells were
selected in 10 lg/ml of blasticidin S (Thermo Scientific) for 7 days
and then tested for genomic integration of the cassette and consis-
tent overexpression of the full-length lnc-SMaRT transcript.
TUNEL assay
Apoptotic quantification was performed by using In Situ Cell Death
Detection Kit, Fluorescein (Roche 11684795910) according to the
manufacturer’s instructions with minor modifications. Briefly, PFA-
fixed-differentiated C2C12 cells were permeabilized with 0.3%
Triton X-100/PBS on ice for 15 min. After extensive washing with
PBS, cells were incubated with TUNEL reaction mixture (Enzyme
solution diluted 1:10 with Label Fluorescein solution) at 37°C for
2 h in Top Brite automatic slide hybridizer (Resnova). Following
two washes with PBS, DAPI solution (1 lg/ml) was added at room
temperature for 5 min. Finally, samples were mounted with
ProLong Diamond Antifade Mountant (ThermoFisher Scientific P-
36961), and the images were acquired using a LUCPlanFLN 20×
objective (NA 0.45) and a UPLANSApo 60× oil objective (NA 1.35)
and collected as described in “image analysis” section. The
apoptotic rate indicates the percentage of apoptotic cells with
respect to the total number of nuclei; it was quantified by manual
counting of Fluorescein-labeled nuclei (with DNA strand breaks
generated during apoptosis) and DAPI-labeled nuclei in a micro-
scope field. The value of the apoptotic rate was represented as mean
 SEM of two biological replicates.
Luciferase Reporter constructs
The RLuc-Mlx 50 construct was obtained by cloning the exon 1 of
MLX c in Ψcheck2 vector (Promega) upstream the Renilla luciferase
coding sequence previously depleted of its start codon by inverse
PCR (see the scheme in Fig 4A); the In-Fusion HD Cloning Kit (Clon-
tech) was used. The RLuc-Mlx 50–30 and RLuc-Mlx 30 reporter
constructs were obtained cloning the MLX 30UTR sequence in the
RLuc-Mlx 50 or in the Ψcheck2 vector (Promega) using XhoI and
NotI restriction enzymes (Thermo Scientific).
In the RLuc-Mlx D75 mutant, a deletion of 75 bp was obtained by
inverse PCR with divergent primers from the full-length RLuc-Mlx 50
construct. The RLuc-Mlxmut30 mutant was generated by inverse
PCR with divergent primers.
Oligonucleotides are listed in Table EV4.
Luciferase assays
C2C12, HeLa, or N2a cells were transiently transfected with the luci-
ferase reporter plasmids in the indicated combinations, using Lipo-
fectamine-2000 Reagent (Thermo Scientific). The reporter plasmids
also contain the Firefly luciferase (FLuc) gene to normalize for
transfection efficiency. 48 h after transfection, cells were lysed, and
RLuc and FLuc activities were measured by Dual Glo Luciferase
assay (Promega). Transfection of each construct was performed in
triplicate as well as Luciferase assays. Ratios of RLuc readings to
FLuc readings were taken for each experiment, and triplicates were
averaged.
In-gel G-quadruplex staining
G-quadruplex formation and in-gel staining were carried out as
described in ref. [30]. The oligonucleotide sequences are listed in
Table EV4.
RNA sequencing and bioinformatics analyses
TruSeq Stranded Total RNA Library Prep Kit with Ribo-Zero Gold
was used to prepare cDNA libraries for both lnc-SMaRT depletion
and pull-down RNA-Seq experiments. The sequencing reactions,
performed on an Illumina Hiseq 2500 Sequencing system at the
Institute of Applied Genomics (IGA; Udine, Italy), produced an aver-
age of 21.6 million 100 nucleotide long paired-end read pairs per
sample for the depletion and an average of 55.8 million 50 nucleo-
tide long single-end reads per sample for the lnc-SMaRT pull-down
experiment. Reads from both experiments were pre-processed using
Trimmomatic software [56] which removed adapter sequences and
poor quality bases, filtering out those reads whose length after trim-
ming was less than 30 nucleotides. Then, Bowtie 2 [57] was used to
identify and discard reads mapping to rRNAs and tRNAs. In order to
calculate the distribution of the inner distance between mate pairs,
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reads from depletion experiment were aligned to a non-redundant
set of murine RNA sequences derived from Ensembl 77 mouse
annotation [58] using BWA software [59]. We estimated mean and
variance of the inner distance distribution from aligned read pairs
whose inner distance was within interval [Q1-2(Q3-Q1),Q3 + 2(Q3-
Q1)] (Q1 = first quartile, Q3 = third quartile). TopHat2 [60] was
employed to align reads to GRCm38 mouse genome and Ensembl 77
transcriptome using parameters -i 50 -r 40 –mate-std-dev 80 –
library-type fr-firststrand for depletion and -i 50 –library-type fr-first-
strand for pull-down experiment. Reads mapping to mitochondrial
genome were filtered out. Read numbers and mapping statistics are
reported in Table EV2 (lnc-SMaRT depletion) and Table EV3 (lnc-
SMaRT pull-down).
For the depletion experiment, we used Htseq-count software in
intersection-strict mode [61] to count reads mapping to Ensembl 77
genes. edgeR R package [62] was used to perform differential gene
expression analysis after filtering out genes with a CPM (Count Per
Million) value less than 1 in at least two samples. TMM and GLM
robust normalization were applied to read counts. Model fitting and
testing was performed using glmFIT and glmLRT functions. Dif-
ferentially expressed genes were selected using an FDR cutoff of
0.05. Heatmap of differentially expressed protein-coding genes was
drawn based on log2-transformed RPKM values, calculated using
the edgeR rpkm function. MDS plot was drawn using edgeR
plotMDS function. Gene ontology biological process term enrich-
ment analysis was performed using DAVID Functional Annotation
Tool [63] on protein-coding genes upregulated and downregulated
after lnc-SMaRT depletion, using all protein-coding genes tested for
differential expression as background. The GOsummaries R package
[64] was used to create a word cloud for the enriched GO terms
(Benjamini–Hochberg-corrected P-value < 0.05).
Aligned reads from pull-down experiment were further processed
using Picard MarkDuplicates (available at http://broadinstitute.
github.io/picard) to remove duplicate reads and Bamtools [65] to fil-
ter out reads mapping to multiple positions.
Piranha tool [66] was used to call peaks for lnc-SMaRT pull-
down and LacZ pull-down reads, using Input reads as a covariate
(lnc-SMaRT_VS_Input and LacZ_VS_Input, respectively); bin size
was set to 200. Peaks were also called for lnc-SMaRT pull-down
versus LacZ pull-down (lnc-SmaRT_VS_LacZ). Transcripts bound
by lnc-SMaRT were selected as those whose exons overlapped peaks
from both lnc-SmaRT_VS_Input and lnc-SmaRT_VS_LacZ and did
not overlap peaks from LacZ_VS_Input. BEDtools intersect tool [67]
was used to evaluate these overlaps.
RNA–RNA interaction prediction was computed using IntaRNA
2.3.0 [68] and with -n 3 setting. Graphic representations of IntaRNA
interactions between lnc-SMaRT and MLX were computed
using Forna [69]. C++ implementation of QGRS mapping algorithm
[32] with -t 3 –s 35 settings was used for G-quadruplexes predic-
tions.
Evolutionary conservation of specific Mlx transcript isoforms
was based on the analysis of intron-spanning reads from RNA-Seq
data retrieved from Ensembl [70] database.
Statistical analyses
Unless stated otherwise, data are shown as mean  SEM; the
number of biological replicates is indicated in each Figure legend.
Scatter-and-bar plots have been used to show individual biological
replicate values. Statistical tests used to assess significance of
differences between means are indicated in each Figure legend.
P-values below 0.05 were marked by 1 asterisk, while 2 asterisks
indicate a P-value < 0.01 and 3 asterisks a P-value < 0.001.
P-values < 0.05 were considered significant.
Data availability
The RNA-Seq data from this publication have been deposited to the
GEO database (https://www.ncbi.nlm.nih.gov/geo/) and assigned
the identifier GSE128486.
Expanded View for this article is available online.
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